openPR Logo
Press release

Self-Administered Parenteral Market Competitive And Growth Analysis 2024 | Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC

Self-Administered Parenteral Global Market Report 2024

Self-Administered Parenteral Global Market Report 2024

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Self-Administered Parenteral Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $29.8 billion In 2028 At A CAGR Of 4.9% :

The self-administered parenteral market size has grown strongly in recent years. It will grow from $23.14 billion in 2023 to $24.57 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rise in chronic diseases, aging population, government initiatives, patient education and support programs, the rising incidences of bone disorders.

The self-administered parenteral market size is expected to see steady growth in the next few years. It will grow to $29.8 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing patient preference for home healthcare, telemedicine and remote patient monitoring, patient education and support initiatives, growing personalized medicine. Major trends in the forecast period include integration of digital health solutions, customized drug delivery systems, emergence of targeted therapies, advancements in biologics.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

Self-Administered Parenteral Market Major Segments
The self-administered parenteral market covered in this report is segmented -

1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

Key Driver - Chronic Diseases Fueling Self-Administered Parenteral Market Expansion

The growing incidence of chronic diseases is expected to propel the growth of the self-administered parenteral market going forward. Chronic diseases are long-lasting medical conditions that generally progress slowly over time and often require ongoing management and treatment. Self-administered parenteral products are used in the management of chronic diseases to manage treatment independently, which can significantly improve adherence compared to oral medication. For instance, in January 2023, according to the National Institutes of Health, a US-based government agency, among the population aged 50 or above, the number of people with at least one chronic disease is expected to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the growing incidence of chronic diseases is driving the growth of the self-administered parenteral market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=13927&type=smp

Prominent Trend - Innovative Autoinjector Solutions Revolutionizing the Self-Administered Parenteral Market

Major companies operating in the self-administered parenteral market are focusing on developing innovative products, such as the UDENYCA autoinjector, to provide increased choice and control, ultimately making treatment more accessible to patients. An autoinjector is a medical device designed to deliver a single dose of a particular drug. It is an intuitive design with administration triggered immediately and reliably by push-on-skin activation. For instance, in May 2023, Coherus BioSciences Inc., a US-based biotech company, launched the UDENYCA autoinjector, a self-administered parenteral medication in the US. The UDENYCA Autoinjector is a single-dose, prefilled autoinjector that offers patients an additional administration option for pegfilgrastim. It is designed to be intuitive, with administration triggered by push-on-skin activation, allowing for reliable and immediate delivery of a full pegfilgrastim dose. Additionally, it offers several user-friendly features that promote successful delivery, including fast dosing, intuitive design, dual coverage, at-home and in-office use, and a reduction of febrile neutropenia risk.

Self-Administered Parenteral Market Players
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the self-administered parenteral market in 2023. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Self-Administered Parenteral Market Report Structure
3. Self-Administered Parenteral Market Trends And Strategies
4. Self-Administered Parenteral Market - Macro Economic Scenario
5. Self-Administered Parenteral Market Size And Growth
…..
27. Self-Administered Parenteral Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Self-Administered Parenteral Market Competitive And Growth Analysis 2024 | Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC here

News-ID: 3510071 • Views:

More Releases from The Business Research Company

Hydrocolloids Global Market Report 2024 by The Business Research Company | Archer-Daniels-Midland Company, Ashland Global Holdings Inc., Cargill Incorporated, CP Kelco US Inc., Darling Ingredients Inc., DuPont de Nemours Inc., Hispanagar S.A., Ingredion I
Hydrocolloids Global Market Report 2024 by The Business Research Company | Arche …
The hydrocolloids market size has grown strongly in recent years. It will grow from $12.02 billion in 2023 to $13.07 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rise in demand for functional foods, rise in pharmaceutical sector, growth in demand for personal care products, rise in e-commerce, emerging markets. The hydrocolloids market
Hyaluronic Acid-based Dermal Fillers Global Market Report 2024 by The Business Research Company | Bohus Biotech AB, AbbVie Inc., Galderma Laboratories L.P., Merz Pharmaceuticals GmbH, Genzyme Corporation, Anika Therapeutics Inc., LG Chem Ltd., Bio plus Co
Hyaluronic Acid-based Dermal Fillers Global Market Report 2024 by The Business R …
The hyaluronic acid-based dermal fillers market size has grown rapidly in recent years. It will grow from $4.47 billion in 2023 to $5 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to aging population, rise in beauty consciousness, social media influence, proliferation of medical spas and aesthetic clinics, rise in e-commerce. The hyaluronic acid-based
Humic Based Biostimulants Global Market Report 2024 by The Business Research Company | Syngenta AG, Biolchim S.P.A., FMC Corporation, Haifa Group, UPL Limited, Bayer AG, Sikko Industries Ltd., Humintech GmbH, Promisol, Novihum Technologies GmbH, Borregaar
Humic Based Biostimulants Global Market Report 2024 by The Business Research Com …
The humic based biostimulants market size has grown rapidly in recent years. It will grow from $0.66 billion in 2023 to $0.75 billion in 2024 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to rise in consumer preference for organic produce, increase in global population, government subsidies and support, expansion of the agriculture industry, increased
Hot Food Processing Equipment Global Market Report 2024 by The Business Research Company | GEA Group Aktiengesellschaft, Bühler AG, The Middleby Corporation, JBT Corporation, Heat and Control Inc., SPX Flow Inc., Tetra Laval International S.A., Alfa Lava
Hot Food Processing Equipment Global Market Report 2024 by The Business Research …
The hot food processing equipment market size has grown strongly in recent years. It will grow from $24.14 billion in 2023 to $26.42 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increased consumer demand for convenient and ready-to-eat foods, growth in the foodservice industry and quick service restaurants (qsrs), expansion of commercial

All 5 Releases


More Releases for Parenteral

Parenteral Nutrition Solutions Market 2022 | Detailed Report
The Parenteral Nutrition Solutions report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry. The Parenteral Nutrition Solutions report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,
Parenteral Packaging Market is Segmented By Packaging Type - small Volume Parent …
Manufacturers of parenteral packaging products are moving away from the ‘drugs for container’ concept and are focusing on providing ‘containers for drugs’ – implying the adoption of appropriate materials to manufacture parenteral containers. The 3P’s driving the global parenteral packaging market are Product, Process, and Patient, and given the increasing focus on sustainability and green initiatives, plastic is slowly being eliminated from the parenteral packaging ecosystem. Companies are shifting towards prefilled and
Parenteral Nutrition Market: Segmentation Details
Braun Melsungen AG, Fresenius SE & Co. KGaA, and Baxter International, Inc., who collectively held 71% of the global parenteral nutrition market, are focusing on improving their line of products, reports Transparency Market Research. The trend of winning approvals for their new formulations from concerned authorities is also helping them gain a significant footprint in the market, observes TMR. Strategic joint ventures are also being considered by companies to expand their
The future of parenteral dug delivery
SMi's 5th Annual Pre-Filled Syringes East Coast Conference and Exhibition (April 11 – 12, Boston, USA) will gather together 100+ CEOs and decision makers in the field of PFS, so entire years’ worth of external meetings could happen in just two days and under one roof! Join the conference to share and benchmark against best practices to ensure optimal development in all aspects of pre-filled syringe production. http://www.pfsamericas.com/openpr The future of
Parenteral Nutrition Market Research Report 2024
Braun Melsungen AG, Fresenius SE & Co. KGaA, and Baxter International, Inc., who collectively held 71% of the global parenteral nutrition market, are focusing on improving their line of products, reports Transparency Market Research. The trend of winning approvals for their new formulations from concerned authorities is also helping them gain a significant footprint in the market, observes TMR. Strategic joint ventures are also being considered by companies to expand their
Parenteral Nutrition Market 2024 By Top Players
Braun Melsungen AG, Fresenius SE & Co. KGaA, and Baxter International, Inc., who collectively held 71% of the global parenteral nutrition market, are focusing on improving their line of products, reports Transparency Market Research. The trend of winning approvals for their new formulations from concerned authorities is also helping them gain a significant footprint in the market, observes TMR. Strategic joint ventures are also being considered by companies to expand their